Use of Nonclonal Serum Immunoglobulin Free Light Chains to Predict Overall Survival in the General Population
- 30 June 2012
- journal article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 87 (6), 517-523
- https://doi.org/10.1016/j.mayocp.2012.03.009
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Elevated Serum Free Light Chains Are Associated With Event-Free and Overall Survival in Two Independent Cohorts of Patients With Diffuse Large B-Cell LymphomaJournal of Clinical Oncology, 2011
- Use of a Medical Records Linkage System to Enumerate a Dynamic Population Over Time: The Rochester Epidemiology ProjectAmerican Journal of Epidemiology, 2011
- Age-related changes in immune function: Effect on airway inflammationJournal of Allergy and Clinical Immunology, 2010
- Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort studyThe Lancet, 2010
- Free light chain: a novel predictor of adverse outcome in chronic lymphocytic leukemiaEuropean Journal of Haematology, 2010
- Circulating Serum Free Light Chains As Predictive Markers of AIDS-Related LymphomaJournal of Clinical Oncology, 2010
- Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndromeAnnals Of The Rheumatic Diseases, 2006
- Inflammation and cancerNature, 2002
- The Threat to Medical-Records ResearchThe New England Journal of Medicine, 1997
- Variance Calculations for Direct Adjusted Survival Curves, with Applications to Testing for No Treatment EffectBiometrical Journal, 1986